ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

RNA Avidity Biosciences Inc

24.36
0.53 (2.22%)
After Hours
Last Updated: 15:00:17
Delayed by 15 minutes

Period:

Draw Mode:

Volume 1,034,629
Bid Price 23.90
Ask Price 24.84
News -
Day High 24.76

Low
4.825

52 Week Range

High
27.66

Day Low 23.49
Share Name Share Symbol Market Stock Type
Avidity Biosciences Inc RNA NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.53 2.22% 24.36 15:00:17
Open Price Low Price High Price Close Price Previous Close
24.01 23.49 24.76 24.36 23.83
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
11,484 1,034,629 US$ 24.15 US$ 24,985,793 - 4.825 - 27.66
Last Trade Type Quantity Price Currency
15:20:00 formt 576 US$ 24.36 USD

Avidity Biosciences Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
1.94B 79.72M - 9.56M -212.22M -2.66 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Avidity Biosciences News

Date Time Source News Article
4/22/202415:05PR Newswire (US)Avidity Biosciences Announces Inducement Grants Under Nasdaq..
3/27/202408:00PR Newswire (US)Avidity Biosciences to Participate in Upcoming Investor..
3/21/202415:05PR Newswire (US)Avidity Biosciences Announces Inducement Grants Under Nasdaq..
3/08/202415:23Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
3/05/202415:53Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
3/04/202406:07Edgar (US Regulatory)Form 8-K - Current report
3/04/202406:00PR Newswire (US)Avidity Biosciences Announces Positive AOC 1001 Long-term..
3/01/202415:31Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
2/29/202415:19Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee..
2/29/202415:06Edgar (US Regulatory)Form 8-K - Current report
2/29/202411:00PR Newswire (US)Avidity Biosciences Honors Rare Disease Day®
2/29/202406:00PR Newswire (US)Avidity Biosciences Announces Oversubscribed $400 Million..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No RNA Message Board. Create One! See More Posts on RNA Message Board See More Message Board Posts

Historical RNA Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week22.8926.0222.2424.05911,6681.476.42%
1 Month25.5527.6621.5624.59952,191-1.19-4.66%
3 Months12.0327.6611.2320.921,167,39212.33102.49%
6 Months5.1127.664.82513.641,286,72919.25376.71%
1 Year16.8727.664.82512.011,146,4017.4944.40%
3 Years22.9029.594.82515.39785,5561.466.38%
5 Years26.5037.464.82516.43665,952-2.14-8.08%

Avidity Biosciences Description

Avidity Biosciences Inc is a biotechnology company. The company develops novel Antibody Oligonucleotide Conjugates therapies designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Its product candidate AOC 1001, is designed to treat a rare monogenic muscle disease.

Your Recent History

Delayed Upgrade Clock